When most people think of cannabis, two compounds usually come to mind: THC and CBD. They are the market-driving cannabinoids, the ones that have defined conversations around cannabis quality and potency for decades. But they are only part of the story.
Cannabis produces dozens of cannabinoids, each with unique effects, aromas, and potential benefits. As cultivators and consumers learn more, it is becoming clear that the future of cannabis is about the entire spectrum, not just two molecules.
THC and CBD: The Basics
THC (tetrahydrocannabinol) is the compound most associated with the cannabis high. It binds with receptors in the brain and body to create euphoria, relaxation, or stimulation depending on the dose, environment, and the individual.
CBD (cannabidiol) is non-intoxicating and has been studied for its potential to reduce inflammation, calm anxiety, and balance the effects of THC. Many people seek out CBD for wellness without the strong psychoactive experience.
Beyond the Big Two
CBG (cannabigerol): Sometimes called the “mother cannabinoid” because other cannabinoids are derived from it. CBG shows potential for focus and calm while also being studied for digestive health.
CBN (cannabinol): Often associated with aged cannabis, CBN may play a role in sleep and deep relaxation.
THCV (tetrahydrocannabivarin): Found in smaller amounts, THCV has gained attention for its clear-headed, energetic feel and is being studied for metabolic health.
CBC (cannabichromene): Less well known but promising, CBC has shown anti-inflammatory and neuroprotective properties in early research.
The Entourage Effect
Cannabinoids rarely act alone. When THC, CBD, and these minor cannabinoids interact with terpenes and flavonoids, they create what researchers call the entourage effect. This synergy is why two strains with the same THC percentage can feel completely different. The whole chemical profile, or chemovar, is what defines the experience.
Our strain Prism is a perfect example. In 2023, it won the Golden Bear Best of California award at the CA State Fair Cannabis Awards, recognized for a cannabinoid profile that tested around 26% THC with an unusually high 6.9% CBGa. That combination, along with its terpene expression, strong in Ocimene, made Prism stand out among hundreds of entries. Awards like this highlight why looking beyond THC and CBD matters. The entire spectrum of cannabinoids can shape both experience and therapeutic potential.
Why It Matters
Understanding cannabinoids helps us make more informed choices as consumers and cultivators. For medical patients, it can mean finding relief with fewer side effects. For recreational users, it opens up new ways to explore flavor, mood, and creativity. For breeders, it provides a roadmap to create the next generation of strains bred for specific experiences.
At Nimbus, we see cannabinoids as part of the bigger picture of cannabis: a plant that is as complex as it is inspiring. By paying attention to the full spectrum, we can unlock new flavors, effects, and wellness potential while continuing to push cannabis forward.
